Investor

Teikoku Ventures, Inc.

Other Domestic (Japan)

2026 activity

Grey amounts aren't counted in totals. † includes debt or other non-equity.

DateCompanyStageAmountInvestorsSector
5 Oct 2026 STSereido Therapeutics Series B 2nd Close ¥400M Shionogi & Co.Teikoku Ventures, Inc. BiotechDeep tech